Patents for A61K 49 - Preparations for testing in vivo (35,376)
01/2013
01/29/2013US8361443 Peptide-based compounds
01/29/2013US8361442 Oxime conjugates and methods for their formation and use
01/29/2013US8361441 Detection and therapy of bacterial infection caused by Enterobacteriaceae
01/29/2013US8361440 Imaging method and device for carrying out said method
01/29/2013US8361438 N-alkoxyamide conjugates as imaging agents
01/29/2013US8361437 Multimodal nanoparticles for non-invasive bio-imaging
01/29/2013CA2522645C New monoclonal antibody capable of binding integrin alpha10beta1
01/24/2013WO2013013067A2 Microbubble compositions, method of making same, and method using same
01/24/2013WO2013013055A1 System for drug delivery and monitoring
01/24/2013WO2013012754A1 Boron-based dual imaging probes, compositions and methods for rapid aqueous f-18 labeling, and imaging methods using same
01/24/2013WO2013011984A1 Fluorescent probe and method for producing same
01/24/2013US20130024955 Method for determining genotoxicity using non-fluorescent proteins
01/24/2013US20130024953 Methods of Treating Disorders Associated with Protein Aggregation
01/24/2013US20130023736 Systems for drug delivery and monitoring
01/24/2013US20130023714 Medical and Imaging Nanoclusters
01/24/2013US20130022990 Cellular labeling for nuclear magnetic resonance techniques
01/24/2013US20130022551 DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS
01/24/2013US20130022550 Microbubble Compositions, Method of Making Same, and Method Using Same
01/24/2013US20130022549 Halogenated phenols for diagnostics, antioxidant protection and drug delivery
01/24/2013US20130022548 Methods and Compositions Relating to Reporter Gels for Use in MRI Techniques
01/24/2013US20130022547 Attenuated mycoplasma gallisepticum strains
01/24/2013US20130022546 Peptides that Specifically Target Amyloid Deposits
01/24/2013US20130022545 DRUG DELIVERY SYSTEM FOR TREATMENT OF LIVER CANCER BASED ON INTERVENTIONAL INJECTION OF TEMPERATURE AND pH-SENSITIVE HYDROGEL
01/24/2013US20130022544 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
01/24/2013US20130022543 Method for Treating and Confirming Diagnosis of Exertional Compartment Syndrome
01/24/2013US20130022538 Aptamer-mrna conjugates for targeted protein or peptide expression and methods for their use
01/24/2013DE102011108114A1 Device, useful for generating magnetic gradient fields having a field-free line, comprises an arrangement of electrical conductors extending on a cylinder jacket parallel to a cylinder axis, and an energization unit
01/23/2013EP2548546A1 X-ray opaque infiltrant
01/23/2013EP2547369A1 A nanoparticle comprising a micelle formed by an amphiphilic block- copolymer and encapsulating a gadolinium complex
01/23/2013EP2547367A1 System for improved delivery of gene modulating compounds
01/23/2013EP2547311A1 Kit and method for detecting porous dental hydroxy apatite
01/23/2013CN102892434A Process for preparing hyperpolarized substrates and method for mri
01/23/2013CN102892433A Staining composition
01/23/2013CN102887833A Iodine-containing dimer contrast medium
01/23/2013CN102887546A Water-soluble ferroferric oxide nano particle, preparation method and application thereof
01/23/2013CN102886053A Composite nano capsule having ultrasonic/MRI (Magnetic Resonance Imaging) dual response and preparation method thereof
01/23/2013CN102886048A Building method for medicament transportation or radiography carrier containing coat protein and inorganic nanoparticles
01/23/2013CN102465117B Chimeric simian/human immunodeficency virus strain and application thereof
01/23/2013CN102441180B Gastrointestinal B-ultrasonic developer
01/23/2013CN102238908B Method for measuring physiological parameters in cerebral interstitial fluid and cerebral extracellular space
01/23/2013CN101991867B Multi-mode targeted probe for early hepatic fibrosis diagnosis and preparation method thereof
01/23/2013CN101954096B Multifunctional ultrasound contrast agent and preparation method thereof
01/23/2013CN101854956B Imaging medium comprising hyperpolarised 13C-acetate and use thereof
01/23/2013CN101378785B Compositions comprising magnetic iron oxide particles and use thereof in medical imaging
01/22/2013US8357506 Method of identifying improved conjugates of biologically active compounds
01/22/2013US8357351 Nano-scale contrast agents and methods of use
01/22/2013CA2575677C Gas-filled microvesicles composition for contrast imaging
01/22/2013CA2455638C Peptide-based multimeric targeted contrast agents
01/22/2013CA2416307C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
01/17/2013WO2013010176A2 Pharmacophores for amyloid fibers involved in alzheimer's disease
01/17/2013WO2013009701A2 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
01/17/2013WO2013009475A1 Photosensitizing antibody-phuorophore conjugates
01/17/2013WO2012157900A3 18f-labeled precursor of pet radioactive medical supplies, and preparation method thereof
01/17/2013WO2012136813A3 Agents for medical radar diagnosis
01/17/2013US20130017155 Dual ct/mri nanoparticle contrast agent
01/17/2013US20130017153 Unit dosage of apadenoson
01/17/2013US20130017152 Method for the treatment of multiple sclerosis
01/17/2013US20130017151 SUBSETS OF ANTIGEN-PRESENTING CELLS (APCs) IN THE HUMAN VAGINA AND THEIR DISTINCT FUNCTIONS
01/17/2013US20130017148 Systems for producing multilayered particles, fibers and sprays and methods for administering the same
01/17/2013US20130017147 Targeting agent for tumor site
01/17/2013DE19941675B4 2-Amino-bicyclo[3.1.0] hexan-2,6-dicarbonsäurederivate und ein Verfahren zu deren Herstellung 2-amino-bicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivatives and a process for their preparation
01/17/2013CA2841120A1 Photosensitizing antibody-fluorophore conjugates
01/16/2013EP2546269A1 Monoclonal antibody against necrosis marker prdx4 and use thereof
01/16/2013EP2546266A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF
01/16/2013EP2545908A1 Medium for microbubbles or microparticles and preparation thereof
01/16/2013EP2545085A1 Radiopaque, non- biodegradable, water - insoluble iodinated benzyl ethers of poly (vinyl alcohol), preparation method thereof, injectable embolizing compositions containing thereof and use thereof
01/16/2013EP2544723A2 Compositions for colon lavage and methods of making and using same
01/16/2013CN102876328A Near-infrared fluorescent nanoparticle in-vivo probe and preparation method thereof
01/16/2013CN102875647A Ligand polypeptide and medicine transferring system combined with specificity of CD40L protein
01/16/2013CN102872463A Nanoparticles comprising rna ligands
01/16/2013CN102871986A Systems and methods for producing multilayered particles, fibers and sprays and methods for administering the same
01/16/2013CN101757643B Emulsion based on stabilizing agent, preparation method and application thereof
01/10/2013WO2013006520A1 Compositions and methods for metabolic imaging
01/10/2013WO2013004518A1 Ultrasonic couplant spray
01/10/2013US20130012913 Injectable cross-linked hydrogels for biomaterial applications
01/10/2013US20130011903 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities
01/10/2013US20130011340 Compositions and methods comprising magnetic resonance contrast agents
01/10/2013US20130011339 Nanoparticle compositions comprising a lipid bilayer and associated methods
01/10/2013US20130011338 Cupredoxin derived transport agents and methods of use thereof
01/10/2013US20130011337 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases
01/10/2013US20130011336 Imaging agents of fibrotic diseases
01/10/2013US20130011333 Methods and Compositions for Nanoparticle-Mediated Cancer Cell-Targeted Delivery
01/10/2013US20130011332 Frozen Compositions and Methods for Piercing a Substrate
01/10/2013CA2840595A1 Compositions and methods for metabolic imaging
01/09/2013EP2543666A1 Radioactive iodine labeled organic compound or salt thereof
01/09/2013EP2542643A2 Near-ir indocyanine green doped multimodal silica nanoparticles and methods for making the same
01/09/2013EP2542268A1 Solid composition for the oral administration of dyes and diagnostic use thereof
01/09/2013EP2542264A1 Magnetic nanoparticles for cancer diagnostic and treatment purposes
01/09/2013EP2542235A1 Use of riluzole to treat or prevent the adverse effects of antineoplastic agents
01/09/2013CN102863026A Water-dispersible manganese-doped magnetic nano-cluster, and preparation method and application thereof
01/09/2013CN102861345A Preparation method of polymer microvesicle ultrasonic contrast agent
01/09/2013CN102861344A Preparation of gold nanoparticle coated with folic acid-modified pegylated dendrimer
01/09/2013CN102488904B Gastric mucosa targeting super-paramagnetic magnetic resonance contrast medium composition and preparation method thereof
01/09/2013CN102068704B Dental plaque detection liquid
01/09/2013CN101786601B Preparation method of compound nano particle with Fe3O4/CoO core shell structure
01/09/2013CN101232905B Oral preparation useful in measuring capacity to metabolize pyridine
01/08/2013US8349294 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
01/08/2013US8349292 Treatment of allergic otitis media in mammals with Clostridia neurotoxins
01/08/2013CA2489004C Agonistic binding molecules to the human ox40 receptor
01/03/2013WO2013003507A1 Multifunctional agents
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 354